Skip to main content
NXPL
NASDAQ Technology

NextPlat Buys Florida Pharmacy for $1.5M, Adding $5.6M in Revenue

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Positive
Importance info
7
Price
$6.89
Mkt Cap
$17.903M
52W Low
$3.375
52W High
$11.1
52W Position info
104% above low
Off High info
38% below high
Rel. Volume info
3.5× avg
Market data snapshot near publication time

NXPL has more than doubled off its 52-week low of $3.375 on elevated volume (3.5× avg).

Summary

NextPlat Corp agreed to acquire Scott's Pharmacy, a profitable rural pharmacy in northwest Florida, for $1.5 million in cash. The target generated $5.6 million in 2025 revenue and expands NextPlat's pharmacy footprint into an underserved market.


Key Events · M&A and Partnerships · NXPL

  • Acquisition of Scott's Pharmacy

    Progressive Care, LLC, a subsidiary of NextPlat, entered into an agreement to acquire 100% of Scott's Pharmacy, LLC, a community pharmacy in Molino, Florida, for $1.5 million in cash, subject to a post-signing inventory adjustment.

  • Financial Impact

    The target generated approximately $5.6 million in revenue in 2025 with retail margins of about 19% and was profitable with a debt-free balance sheet. The acquisition is expected to be immediately accretive and supports NextPlat's 20% organic growth target for 2026.

  • Strategic Expansion

    The deal expands PharmcoRx's retail footprint into an underserved rural market in northwest Florida, where NextPlat plans to introduce same-day delivery, online fulfillment, and higher-margin 340B contracted services for healthcare providers.

  • Closing Timeline

    Closing is targeted by September 30, 2026, with a one-time extension to October 31, 2026, available upon notice and an additional $50,000 deposit. The transaction is subject to due diligence and customary closing conditions.


Analysis · NXPL · Technology

NextPlat is acquiring Scott's Pharmacy, a profitable rural pharmacy near Pensacola, for $1.5 million in cash. The target generated about $5.6 million in 2025 revenue with 19% retail margins and a debt-free balance sheet. This bolt-on acquisition expands NextPlat's PharmcoRx retail footprint into an underserved market and creates a platform to roll out higher-margin 340B contracted services. While the deal is small relative to NextPlat's $54.3 million in 2025 revenue, it signals a replicable growth strategy in rural Florida. The company expects 20% organic growth in 2026, and this acquisition adds immediate scale and profitability. Closing is targeted by September 30, 2026, with a one-time extension to October 31.

At the time of this filing, NXPL was trading at $6.89 on NASDAQ in the Technology sector, with a market capitalization of approximately $17.9M. The 52-week trading range was $3.38 to $11.10. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NXPL - Latest Insights

NXPL
Jul 16, 2026, 6:03 AM EDT
Source: Wiseek News
Importance Score:
7
NXPL
Jul 15, 2026, 6:20 PM EDT
Filing Type: 8-K
Importance Score:
7
NXPL
Jul 15, 2026, 8:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
NXPL
Jun 08, 2026, 4:03 PM EDT
Filing Type: 424B3
Importance Score:
9
NXPL
Jun 02, 2026, 7:34 PM EDT
Filing Type: S-3/A
Importance Score:
9
NXPL
May 14, 2026, 5:45 PM EDT
Filing Type: 10-Q
Importance Score:
9
NXPL
May 14, 2026, 2:02 PM EDT
Filing Type: 8-K
Importance Score:
8
NXPL
May 14, 2026, 8:01 AM EDT
Source: Reuters
Importance Score:
7
NXPL
May 13, 2026, 4:30 PM EDT
Filing Type: 424B5
Importance Score:
8
NXPL
May 06, 2026, 4:29 PM EDT
Filing Type: S-3
Importance Score:
9